Acquired Thrombotic Thrombocytopenic Purpura
📧 Sign up to get email alerts when something new happens for Acquired Thrombotic Thrombocytopenic Purpura.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP [Phase 2]
A Phase 2 trial evaluating a personalized caplacizumab regimen guided by ADAMTS13 activity in adults with acquired thrombotic thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2, Phase 3]
This update reports completion of Phase 2/Phase 3 trials of caplacizumab in Japanese patients with acquired thrombotic thrombocytopenic purp…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Platelet Response to Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura
The update reports on platelet response to caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura, based on a complet…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2]
Phase 2 trial of rADAMTS-13 (SHP655) for acquired thrombotic thrombocytopenic purpura (aTTP) has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) [Phase 3]
Follow-up study for patients who completed the Phase 3 HERCULES trial (ALX0681-C301) in acquired thrombotic thrombocytopenic purpura has com…
-
CLINICAL_TRIALS trial_result · 2019-07-17Clinical Trial Update: A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]
Phase 2 clinical trial update for anfibatide in acquired thrombotic thrombocytopenic purpura (TTP) is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) [Phase 2]
Phase 2 trial evaluating an anti-von Willebrand Factor nanobody for safety and efficacy in acquired thrombotic thrombocytopenic purpura has …
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura [Phase 3]
Phase III trial of caplacizumab in acquired thrombotic thrombocytopenic purpura has completed with results posted.